Cargando…
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent airflow limitation that is not fully reversible and is currently the fourth leading cause of death globally. It is now well established that cardiovascular-related comorbidities contribute to morbidity and mortalit...
Autores principales: | Brassington, Kurt, Selemidis, Stavros, Bozinovski, Steven, Vlahos, Ross |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465303/ https://www.ncbi.nlm.nih.gov/pubmed/30979844 http://dx.doi.org/10.1042/CS20180316 |
Ejemplares similares
-
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics
por: Brassington, Kurt, et al.
Publicado: (2022) -
Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies
por: Chan, Stanley M.H., et al.
Publicado: (2019) -
Role of Alveolar Macrophages in Chronic Obstructive Pulmonary Disease
por: Vlahos, Ross, et al.
Publicado: (2014) -
Ebselen reduces cigarette smoke‐induced endothelial dysfunction in mice
por: Brassington, Kurt, et al.
Publicado: (2021) -
Influenza A Virus-Driven Airway Inflammation may be Dissociated From Limb Muscle Atrophy in Cigarette Smoke-Exposed Mice
por: Mou, Kevin, et al.
Publicado: (2022)